Multi-drug-resistant tuberculosis risk factors: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Multi-drug-resistant tuberculosis}} {{CMG}} ==Overview== ==References== {{reflist|2}} {{WH}}" |
m Changes made per Mahshid's request |
||
| (9 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Multi-drug-resistant tuberculosis}} | {{Multi-drug-resistant tuberculosis}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{AL}} | ||
==Overview== | ==Overview== | ||
Risk factors for multi-drug resistant tuberculosis include exposure to an individual with MDR-TB, previous TB treatment, HIV infection, and a low socioeconomic status. | |||
==Risk Factors== | |||
*The risk factor for developing multi-drug resistant tuberculosis include:<ref>{{Cite journal | |||
| author = [[Z. Mor]], [[D. Goldblatt]], [[H. Kaidar-Shwartz]], [[N. Cedar]], [[E. Rorman]] & [[D. Chemtob]] | |||
| title = Drug-resistant tuberculosis in Israel: risk factors and treatment outcomes | |||
| journal = [[The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease]] | |||
| volume = 18 | |||
| issue = 10 | |||
| pages = 1195–1201 | |||
| year = 2014 | |||
| month = October | |||
| doi = 10.5588/ijtld.14.0192 | |||
| pmid = 25216833 | |||
}}</ref><ref>{{Cite journal | |||
| author = [[Mahfuza Rifat]], [[Abul Hasnat Milton]], [[John Hall]], [[Christopher Oldmeadow]], [[Md Akramul Islam]], [[Ashaque Husain]], [[Md Wahiduzzaman Akhanda]] & [[Bodrun Naher Siddiquea]] | |||
| title = Development of multidrug resistant tuberculosis in bangladesh: a case-control study on risk factors | |||
| journal = [[PloS one]] | |||
| volume = 9 | |||
| issue = 8 | |||
| pages = e105214 | |||
| year = 2014 | |||
| month = | |||
| doi = 10.1371/journal.pone.0105214 | |||
| pmid = 25136966 | |||
}}</ref><ref name=WHO>{{cite web | title = Multidrug-resistant tuberculosis | url = http://www.who.int/tb/challenges/mdr/en/ }}</ref> | |||
:*Exposure to a patient with MDR-TB | |||
:*Previous TB treatment | |||
:*HIV infection | |||
:*Previous incarceration | |||
:*Failed TB treatment | |||
:*Relapse following standard TB treatment | |||
:*Low income and low socioeconomic class | |||
:*Individuals that come from areas of the world where [[drug-resistant]] [[TB]] is common | |||
:*Individuals that have spent time with someone known to have [[drug-resistant]] [[TB]] disease | |||
*Adverse reactions of the drugs used in the treatment of tuberculosis contribute to the cease of the drug regimen and increases the probability of multi-drug resistance. | |||
*Direct observed treatment plays an important role to avoid drop-outs from tuberculosis medical regimen, which is an important risk factor for developing resistance to the standard medical regimen. | |||
<br> | |||
{{further|[[Tuberculosis risk factors]]}} | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | |||
[[Category:Needs content]] | |||
[[Category:Disease]] | |||
[[Category:Bacterial diseases]] | |||
[[Category:Pulmonology]] | |||
[[Category:Tuberculosis]] | |||
Latest revision as of 18:07, 18 September 2017
|
Multi-drug-resistant tuberculosis Microchapters |
|
Differentiating Multi-drug-resistant tuberculosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Multi-drug-resistant tuberculosis risk factors On the Web |
|
American Roentgen Ray Society Images of Multi-drug-resistant tuberculosis risk factors |
|
Directions to Hospitals Treating Multi-drug-resistant tuberculosis |
|
Risk calculators and risk factors for Multi-drug-resistant tuberculosis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]
Overview
Risk factors for multi-drug resistant tuberculosis include exposure to an individual with MDR-TB, previous TB treatment, HIV infection, and a low socioeconomic status.
Risk Factors
- Exposure to a patient with MDR-TB
- Previous TB treatment
- HIV infection
- Previous incarceration
- Failed TB treatment
- Relapse following standard TB treatment
- Low income and low socioeconomic class
- Individuals that come from areas of the world where drug-resistant TB is common
- Individuals that have spent time with someone known to have drug-resistant TB disease
- Adverse reactions of the drugs used in the treatment of tuberculosis contribute to the cease of the drug regimen and increases the probability of multi-drug resistance.
- Direct observed treatment plays an important role to avoid drop-outs from tuberculosis medical regimen, which is an important risk factor for developing resistance to the standard medical regimen.
References
- ↑ Z. Mor, D. Goldblatt, H. Kaidar-Shwartz, N. Cedar, E. Rorman & D. Chemtob (2014). "Drug-resistant tuberculosis in Israel: risk factors and treatment outcomes". The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 18 (10): 1195–1201. doi:10.5588/ijtld.14.0192. PMID 25216833. Unknown parameter
|month=ignored (help) - ↑ Mahfuza Rifat, Abul Hasnat Milton, John Hall, Christopher Oldmeadow, Md Akramul Islam, Ashaque Husain, Md Wahiduzzaman Akhanda & Bodrun Naher Siddiquea (2014). "Development of multidrug resistant tuberculosis in bangladesh: a case-control study on risk factors". PloS one. 9 (8): e105214. doi:10.1371/journal.pone.0105214. PMID 25136966.
- ↑ "Multidrug-resistant tuberculosis".